Breaking News
July 17, 2018 - Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction
July 17, 2018 - AAP: Lawnmowers Pose Serious Injury Risk to Children
July 17, 2018 - Fewer U.S. kids are getting cavities
July 17, 2018 - Differences in brain’s reward circuit may explain social deficits in autism
July 17, 2018 - YCC researchers suggest promising treatment for two rare inherited cancer syndromes
July 17, 2018 - FAU and partners receive NIH research grant to shed light on sleep loss and metabolic disorders
July 17, 2018 - Advanced MRI technique predicts risk of disease progression in MS
July 17, 2018 - Health Tip: Microwave Safely – Drugs.com MedNews
July 17, 2018 - New target for treating heart failure identified
July 17, 2018 - Biodesign fellows simplify heart rhythm monitoring
July 17, 2018 - Study reveals new risk genes for allergic rhinitis
July 17, 2018 - Community college education can increase physician diversity and access to primary care
July 17, 2018 - Inflection Biosciences’ dual mechanism inhibitor shows promise as treatment for CLL
July 17, 2018 - Researchers uncover how cells invite corrupted proteins inside
July 17, 2018 - Studies show HORIBA’s new hematology analyzer improves POCT and care of oncology patients
July 17, 2018 - New website aims to make yoga safer for everyone
July 17, 2018 - Long-term survival worse for black survivors of in-hospital cardiac arrest
July 17, 2018 - Stanford data analyst’s childhood inspires his research: A Q&A
July 17, 2018 - Preventability of hospital readmissions changes over time, study reveals
July 17, 2018 - Nursing notes can help predict if ICU patients will survive
July 17, 2018 - Okayama University research could improve prognosis of diabetic kidney disease
July 17, 2018 - Researchers develop machine learning method to predict unknown gene functions of microbes
July 17, 2018 - Homogenous BTK occupancy assay used in tirabrutinib clinical studies
July 17, 2018 - Study identifies new genes linked to heart function and development
July 17, 2018 - NeuroTrauma Sciences and Henry Ford join hands to advance exosome technology
July 17, 2018 - Improved methods to measure enterococci concentrations in recreational water
July 17, 2018 - White adolescent boys experiencing early puberty have high risk for substance use
July 17, 2018 - Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia
July 17, 2018 - Roots of leukemia reveal possibility of predicting people at risk
July 17, 2018 - Summer med program embraces low-income students’ potential
July 17, 2018 - New research lays foundation to create standards for RNA sequencing
July 17, 2018 - CRISPR/Cas9 gene editing can cause greater genetic damage than previously thought
July 17, 2018 - Democrats rally against threats to the ACA to block Trump’s Supreme Court nominee
July 17, 2018 - Staggering prices slow insurers’ coverage of CAR-T cancer therapy
July 17, 2018 - How proteins involved in neurodegeneration enter cells
July 17, 2018 - New super-resolution ‘nanoscope’ provides insight into progression of Alzheimer’s disease
July 17, 2018 - FDA Advisory Committee Endorses the Effectiveness and Safety of Single-Dose Tafenoquine for the Radical Cure of P. vivax Malaria
July 17, 2018 - Uncovering the evolutionary history of IBD-associated colorectal cancer
July 17, 2018 - Is nutrition research dependable? Stanford’s John Ioannidis weighs in
July 17, 2018 - New machine learning framework predicts effects of genetic mutations in ‘dark matter’ regions
July 17, 2018 - Plant-based products fail to have positive impact on blood pressure during clinical studies
July 17, 2018 - Electronic system to speed up facial pain diagnosis may improve quality of life and save money
July 17, 2018 - Study delves into the role played by Protein Kinase C in synaptic plasticity
July 17, 2018 - Women Often Unaware of Their Hospital’s Religious Affiliation
July 17, 2018 - New AASM guideline recommends use of actigraphy for sleep disorders
July 17, 2018 - CRISPR editing reduces repetitive behavior in mice with a form of autism
July 17, 2018 - Scientists use magnets to detect cancer
July 17, 2018 - Microfluidic chip to detect sepsis proves successful in clinical study
July 17, 2018 - Research provides better understanding of mechanisms underlying memory storage
July 17, 2018 - A Multi-Modal Approach for the Early Detection of Breast Cancer
July 17, 2018 - Mailing colorectal cancer tests to patients increases screening rates, report researchers
July 17, 2018 - Scientists find possible sources of medicinal and antimicrobial drugs
July 17, 2018 - Molecules formed when the body metabolizes omega-3 fatty acids may inhibit cancer
July 17, 2018 - Efficient communication between hospitals improves patient safety and reduces mortality
July 17, 2018 - Study highlights potential of fetal gene therapy to prevent lethal neurodegenerative disease
July 17, 2018 - For Americans, in Science They Trust
July 17, 2018 - Combating HIV/AIDS | NIH MedlinePlus the Magazine
July 17, 2018 - Study shows minorities widely underrepresented in autism diagnoses
July 17, 2018 - Multigene testing replacing BRCA tests for breast cancer risk | News Center
July 17, 2018 - Pre-clinical pilot study shows promising results of ‘concussion pill’
July 17, 2018 - Researchers reduce size of tumors in mice by artificially activating the brain’s reward system
July 17, 2018 - New study documents symptoms of people before they acquire multiple sclerosis
July 17, 2018 - Researchers discover why CRISPR gene editing sometimes fails
July 17, 2018 - New finding may hold key to better understand the complexities of neurological disorders
July 17, 2018 - The Current issue of “The view from here” is concerned with Novel Targets.
July 17, 2018 - Fighting the Flu with a Universal Vaccine
July 17, 2018 - Key social reward circuit in the brain impaired in kids with autism | News Center
July 17, 2018 - Insight into causes, types and treatment of aphasia
July 16, 2018 - Quark Pharmaceuticals, Inc Announces First Patient Dosed in Phase 3 Clinical Trial of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
July 16, 2018 - NSAIDs shown to have causal role in cardiovascular risk of patients with osteoarthritis
July 16, 2018 - PET scan tracer predicts success of cancer ‘vaccine’ | News Center
July 16, 2018 - Parents struggle with what to do when their child has headache, shows study
July 16, 2018 - Outrageous or overblown? HHS announces another round of ACA navigator funding cuts
July 16, 2018 - Weight loss surgery may impact individual’s risk of developing cancer, shows study
July 16, 2018 - Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.
July 16, 2018 - Restoring epigenetic balance reinstates memory in flies with Alzheimer’s disease symptoms
July 16, 2018 - Magnetized wire could be used to detect cancer in people | News Center
July 16, 2018 - Non-surgical management found to be feasible option for penetrating kidney trauma
July 16, 2018 - California clinic screens asylum seekers for honesty
July 16, 2018 - FDA Approves Xtandi (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
Fecal Occult Blood Test (FOBT): MedlinePlus Lab Test Information

Fecal Occult Blood Test (FOBT): MedlinePlus Lab Test Information

image_pdfDownload PDFimage_print

What is a Fecal Occult Blood Test?

A fecal occult blood test (FOBT) looks at a sample of your stool (feces) to check for blood. Occult blood means that you can’t see it with the naked eye. Blood in the stool means there is likely some kind of bleeding in the digestive tract. It may be caused by a variety of conditions, including:

Blood in the stool may also be a sign of colorectal cancer, a type of cancer that starts in the colon or rectum. Colorectal cancer is the second leading cause of cancer-related deaths in the United States and the third most common cancer in men and in women. A fecal occult blood test is a screening test that may help find colorectal cancer early, when treatment is most effective.

Other names: FOBT, stool occult blood, occult blood test, Hemoccult test, guaiac smear test, gFOBT, immunochemical FOBT, iFOBT; FIT

What is it used for?

A fecal occult blood test is used as an early screening test for colorectal cancer. It may also be used to diagnose other conditions that cause bleeding in the digestive tract.

Why do I need a fecal occult blood test?

The National Cancer Institute recommends that people get regular screenings for colorectal cancer starting at age 50. The screening may be a fecal occult test, a colonoscopy, or another test. Talk with your health care provider about which test is right for you.

If you choose a fecal occult blood test, you need to get it every year. If you have a colonoscopy, you only need it every ten years. But it is a more invasive procedure. You may need screening more often if you have certain risk factors. These include:

What happens during a fecal occult blood test?

A fecal occult blood test is a noninvasive test that you can perform at home at your convenience. Your health care provider will give you a kit that includes instructions on how to do the test. There are two main types of fecal occult blood tests: the guaiac smear method (gFOBT) and the immunochemical method (iFOBT or FIT). Below are typical instructions for each test. Your instructions may vary slightly depending on the manufacturer of the test kit.

For a guaiac smear test (gFOBT), you will most likely need to:

  • Collect samples from three separate bowel movements.
  • For each sample, collect the stool and store in a clean container. Make sure the sample does not mix in with urine or water from the toilet.
  • Use the applicator from your test kit to smear some of the stool on the test card or slide, also included in your kit.
  • Label and seal all your samples as directed.
  • Mail the samples to your health care provider or lab.

For a fecal immunochemical test (FIT), you will most likely need to:

  • Collect samples from two or three bowel movements.
  • Collect the sample from the toilet using the special brush or other device that was included in your kit.
  • For each sample, use the brush or device to take the sample from the surface of the stool.
  • Brush the sample onto a test card.
  • Label and seal all your samples as directed.
  • Mail the samples to your health care provider or lab.

Be sure to follow all the instructions provided in your kit, and talk to your health care provider if you have any questions.

Will I need to do anything to prepare for the test?

Certain foods and drugs may affect the results of a guaiac smear method (gFOBT) test. Your health care provider may ask you to avoid the following:

  • Nonsteroidal, anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, or aspirin for seven days prior to your test. If you take aspirin for heart problems, talk to your health care provider before stopping your medicine. Acetaminophen may be safe to use during this time, but check with your health care provider before taking it.
  • More than 250 mg of vitamin C daily from supplements, fruit juices, or fruit for seven days prior to your test. Vitamin C can affect the chemicals in the test and cause a negative result even if there is blood present.
  • Red meat, such as beef, lamb, and pork, for three days prior to the test. Traces of blood in these meats may cause a false-positive result.

There are no special preparations or dietary restrictions for a fecal immunochemical test (FIT).

Are there any risks to the test?

There is no known risk to having a fecal occult blood test.

What do the results mean?

If your results are positive for either type of fecal occult blood test, it means you likely have bleeding somewhere in your digestive tract. But it does not necessarily mean you have cancer. Other conditions that may produce a positive result on a fecal occult blood test include ulcers, hemorrhoids, polyps, and benign tumors. If your test results are positive for blood, your health care provider will likely recommend additional testing, such as a colonoscopy, to figure out the exact location and cause of your bleeding. If you have questions about your results, talk to your health care provider.

Is there anything else I need to know about a fecal occult blood test?

Regular colorectal cancer screenings, such as the fecal occult blood test, are an important tool in the fight against cancer. Studies show that screening tests can help find cancer early, and may reduce deaths from the disease.

Tagged with:

About author

Related Articles